Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Purslane gel is a topical herbal formulation developed by the Qionglai Hospital of Traditional Chinese Medicine for the treatment of acne vulgaris. The active ingredient is derived from *Portulaca oleracea* (purslane), a succulent plant widely used in traditional medicine for its anti-inflammatory, antimicrobial, and antioxidant properties. The gel works by reducing skin inflammation through the inhibition of pro-inflammatory cytokines and the suppression of the NF-κB signaling pathway. Additionally, it exhibits antimicrobial activity against common skin pathogens associated with acne, such as *Cutibacterium acnes*. As a hospital-specific preparation (医院制剂) in China, it is used as a localized therapeutic option to alleviate redness, swelling, and bacterial infection while promoting skin barrier repair.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on purslane gel.